Bajaj Finserv Healthcare Fund · Regular · Growth
NAV
₹11.6500
as of 29 Sept 2026
Expense Ratio
2.59%
AUM
₹330 Cr
Lumpsum returns (CAGR)
- 1Y
- +22.99%
- 3Y
- —
- 5Y
- —
- Since Inception
- +9.09%
SIP returns (XIRR)
- 1Y
- +29.58%
- 3Y
- —
- 5Y
- —
- Since Inception
- +19.92%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Risk Metrics
Trailing 1 year, annualised1.10
Sharpe Ratio
+0.20
Alpha
0.20
Beta
1.08
Sortino
12.33%
Std Dev
-10.58%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology71.29%
- Healthcare Services16.96%
- Food Products2.27%
- Consumer Durables2.00%
- Chemicals & Petrochemicals1.20%
- Financial Technology (Fintech)0.92%
- Insurance0.82%
- Electrical Equipment0.26%
- Fertilizers & Agrochemicals0.25%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Bajaj Finserv Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Divi'S Laboratories Limited10.55%
- 2Sun Pharmaceutical Industries Limited8.21%
- 3Rubicon Research Limited6.81%
- 4Piramal Pharma Limited6.72%
- 5Aurobindo Pharma Limited6.18%
- 6Apollo Hospitals Enterprise Limited6.00%
- 7Torrent Pharmaceuticals Limited5.03%
- 8Neuland Laboratories Limited4.11%
- 9Emcure Pharmaceuticals Limited3.84%
- 10Max Healthcare Institute Limited3.35%
What this fund does
Bajaj Finserv Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Bajaj Finserv Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Bajaj Finserv Mutual Fund. The fund has been operational for over 1 years. It manages assets worth ₹330 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TOTAL RETURN INDEX (TRI). The current expense ratio is 2.59%.